ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Indianapolis, IN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Indianapolis, IN, USA:

Olaparib in Metastatic Breast Cancer

This research study is for patients with metastatic breast cancer.* Metastatic means that the cancer has spread beyond the ...

Active, not recruiting
Somatic Mutation Breast Cancer (BRCA1)
Somatic Mutation Breast Cancer (BRCA2)
Drug: Olaparib

Phase 2

Beth Israel Lahey Health
Beth Israel Lahey Health

Indianapolis, Indiana, United States and 19 other locations

therapy as a treatment after surgery for hormone receptor positive breast cancer.The study drugs involved in this study are:* A com...

Enrolling
Breast Cancer
Hormone Receptor Positive Breast Cancer
Drug: ADJUVANT ENDOCRINE THERAPY
Combination Product: Pertuzumab+TRASTUZUMAB

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Indianapolis, Indiana, United States and 27 other locations

This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...

Active, not recruiting
Breast Cancer
Drug: Pertuzumab
Drug: Trastuzumab

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Indianapolis, Indiana, United States and 9 other locations

carboplatin monotherapy vs. carboplatin combined with tocilizumab in in Black and non-Black patients with metastatic triple negative or ER low breast...

Enrolling
Estrogen-receptor-low Breast Cancer
Metastatic Breast Cancer
Drug: Tocilizumab
Drug: Carboplatin

Phase 2

Kathy Miller

Indianapolis, Indiana, United States and 3 other locations

This clinical trial will assess the safety and early efficacy of Hydroxychloroquine or Avelumab, with or without Palbociclib, in early-stage ER+ breast...

Enrolling
Breast Cancer
Drug: Avelumab
Drug: Palbociclib

Phase 2

Abramson Cancer Center at Penn Medicine
Abramson Cancer Center at Penn Medicine

Indianapolis, Indiana, United States and 6 other locations

The purpose of this study is to find out the possible anti-cancer effect of pelareorep in combination with chemotherapy \[paclitaxel\] and a ...

Active, not recruiting
Breast Cancer Metastatic
Drug: Avelumab
Drug: Paclitaxel

Phase 2

Oncolytics Biotech

Indianapolis, Indiana, United States and 17 other locations

This research study is studying a combination of drugs as a possible treatment for breast cancer.The drugs involved in this study a...

Active, not recruiting
Breast Cancer
Drug: Utomilumab
Drug: Vinorelbine

Phase 2

Adrienne G. Waks

Indianapolis, Indiana, United States and 16 other locations

evaluate the efficacy of this combination in advanced HER2 negative breast cancer that is triple negative or BRCA1/2 positive (defi...

Active, not recruiting
TNBC - Triple-Negative Breast Cancer
Drug: Talazoparib
Drug: Gedatolisib

Phase 1, Phase 2

Kari Wisinski

Indianapolis, Indiana, United States and 4 other locations

Breast cancer is the most common malignancy in the U.S. Targeted therapies such as tamoxifen have been revolutionary in reducing tu ...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab
Drug: Lapatinib

Phase 2

Baylor College of Medicine
Baylor College of Medicine

Indianapolis, Indiana, United States and 7 other locations

This research study is studying how well newly diagnosed breast cancer that has tested positive for a protein called HER2 responds ...

Enrolling
Breast Cancer
HER2-positive Breast Cancer
Drug: Paclitaxel
Drug: trastuzumab-emtansine

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Indianapolis, Indiana, United States and 48 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems